Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
Clinical trial NCT02634463 · COMPLETED
Trial details
- NCT number
- NCT02634463
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-09
- Primary completion
- 2016-11-09
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.